These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 27495233)

  • 1. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
    Sasayama T; Nishihara M; Kondoh T; Hosoda K; Kohmura E
    Int J Cancer; 2009 Sep; 125(6):1407-13. PubMed ID: 19536818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-451 plays a role as tumor suppressor in human glioma cells.
    Nan Y; Han L; Zhang A; Wang G; Jia Z; Yang Y; Yue X; Pu P; Zhong Y; Kang C
    Brain Res; 2010 Nov; 1359():14-21. PubMed ID: 20816946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
    Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
    Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2.
    Hu S; Chen H; Zhang Y; Wang C; Liu K; Wang H; Luo J
    Oncol Rep; 2017 Mar; 37(3):1691-1697. PubMed ID: 28184932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
    Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
    Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
    Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of glioma cell migration and invasiveness by GDF-15.
    Codó P; Weller M; Kaulich K; Schraivogel D; Silginer M; Reifenberger G; Meister G; Roth P
    Oncotarget; 2016 Feb; 7(7):7732-46. PubMed ID: 26741507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.